YAYuval Arnon

Yuval Arnon

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yuval Arnon has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Evaluation of quality of life, weight loss, and evolution of comorbidities at 5 years after ring-augmented one-anastomosis gastric bypass compared with one-anastomosis gastric bypass and sleeve gastrectomy in patients with extreme obesity

    by Nur Alkrinawi, Sofyan Abu Freih, Yuval Arnon, Abu-Swis Shadi, Alex Vakhrushev, Elchanan Quint, Guy Barsky, Chaled Alnakib, Ivan Kukeev, Anton Osyntsov, et al.

    Background: The prevalence of patients with extreme obesity [body mass index (BMI) ≥ 50] has significantly increased over the past three decades, surpassing the rise in the prevalence of overweight individuals in the general population. Ring-augmented one-anastomosis gastric bypass (RA-OAGB) is a modification of standard one-anastomosis gastric bypass (OAGB) designed to enhance the durability of long-term weight-loss and potentially reduce pouch dilation, particularly in patients with extreme obesity. While short-term outcomes appear comparable to other procedures, long-term comparative data remain limited. Methods: In this retrospective single-center study, we compared patients who underwent RA-OAGB with those who underwent OAGB or sleeve gastrectomy (SG) procedures, all with a minimum follow-up of ≥5 years. Data collected included demographics, comorbidities, perioperative outcomes, long-term complications, and patient-reported quality of life. Results: A total of 111 patients were included in our study during the study period – 24 underwent RA-OAGB, 44 OAGB, and 43 SG. Loss to direct follow-up at 5 years was 15% (94/111 patients had direct follow-up), although clinical data were available for all patients through medical records. The RA-OAGB group had a higher baseline BMI than the OAGB and SG groups (55.4 vs. 51.2 and 51.3 kg/m 2 ; P = 0.006). In the unadjusted analysis, median percentage of excess weight loss (%EWL) was 74%, 63%, and 52%, respectively ( P = 0.027), while median percentage of total weight loss (%TWL) was 42.4%, 37.5%, and 28.9%, respectively ( P = 0.017). After adjustment for baseline BMI and follow-up duration, BMI was significantly lower after RA-OAGB compared with SG ( P = 0.025); RA-OAGB remained associated with greater %EWL ( P = 0.001) and %TWL ( P = 0.002) compared with SG. Adjusted associations with symptomatic gastroesophageal reflux disease (GERD) were not statistically significant. Iron-deficiency anemia was more frequent after bypass procedures than after SG. Quality of life and patient satisfaction were high across all groups, with no significant differences in Bariatric Analysis and Reporting Outcome System (BAROS) scores. Conclusion: In this retrospective single-center study, RA-OAGB was associated with greater long-term weight loss than OAGB and SG. However, given the observational design, baseline differences between groups, and limited sample size, these findings should be considered hypothesis-generating and require confirmation in larger prospective multicenter studies.

  • Open Access

    Early 60-Day Morbidity after Sleeve Gastrectomy Versus One-Anastomosis Gastric Bypass: A Propensity-Matched Single-Center Cohort of 2,382 Patients

    by Ohad Guetta, Illia Vasyliev, Anton Osyntsov, Alex Vakhrushev, Sharon Daniel, Yuval Arnon, Oleg Dukhno

    Background: Comparative data on early complications after sleeve gastrectomy (SG) versus one-anastomosis gastric bypass (OAGB) remain limited. Objective: To compare 60-day postoperative morbidity between SG and OAGB while accounting for confounding. Setting: Soroka University Medical Center, Israel. Methods: This is a retrospective cohort study assessing 60-day morbidity in patients undergoing SG and OAGB between 2009 and 2024. Propensity scores (sex, height, BMI, number of previous bariatric surgeries, smoking status, diabetes mellitus, fatty liver, hiatal hernia, cholecystectomy during index surgery, and band removal during index surgery) were used for 1:1 nearest-neighbor matching without replacement. Any potential postoperative events were flagged by utilization triggers (length of stay > 7 days, ICU admission, blood transfusion, CT or upper endoscopy within 60 days) and verified by chart review. The primary outcome of this study was any complication occurring ≤ 60 days from the operation; secondary outcomes included complication types and severity by Clavien-Dindo classification. Results: Of 3,317 patients (SG n = 1,816; OAGB n = 1,501), 1,191 matched pairs were analyzed. Overall, 60-day complications were higher after SG than OAGB (15.4% vs. 11.8%, p = 0.012). SG patients exhibited more Clavien–Dindo grade II (5.1% vs. 2.4%, p > 0.001), IIIa events (1.3% vs. 0.3%, p = 0.003) and IVb events (0.7% vs. 0.1%, p = 0.039). SG patients experienced higher rates of leak (1.8% vs. 0.8%, p = 0.019), abscess (1.2% vs. 0%, p < 0.001), pleural and abdominal fluid collection (1.2% vs. 0.3%, p = 0.007), bleeding (1.6% vs. 0.7%, p = 0.033) and dysphagia/vomiting (3.2% vs. 1.3%, p = 0.001) compared with OAGB patients. OAGB patients presented with more endoscopically diagnosed ulcers (0.7% vs. 0%, p = 0.008) and respiratory complaints (2.2% vs. 0.6%, p < 0.001) compared to SG patients. Among complicated patients, upper endoscopy within 60 days was more frequent after SG (29.3% vs. 17.3%, p = 0.005); ICU length of stay was not different between the groups (0.8 ± 5.4 days in OAGB vs. 1.2 ± 9.1 days in SG, p = 0.5). Conclusions: In a large propensity-matched single-center cohort study, SG showed higher 60-day morbidity than OAGB, primarily of intermediate severity. Limitations include retrospective design, temporal bias, trigger-based ascertainment, and lack of capture of care delivered at external hospitals.